The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
- PMID: 37357548
- PMCID: PMC10249671
- DOI: 10.1002/clt2.12266
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
Conflict of interest statement
Julijana Asllani, Alfred Priftanji, Mehmet Hoxha, Gerta Sinani, George Christoff, Dimitrov Zlatko, Michael Makris, Xenofon Aggelidis, Asja Stipic, Diana Deleanu, Vesna Tomic‐Spiric, Aleksandra Plavsic, Dilsad Mungan, Mitja Kosnik have no conflicts of interest to declare. Nikolaos G. Papadopoulos has received grants from Capricare, Nestle, Numil, Vianex and/or fees for consultancy from Abbott, Abbvie, Astra Zeneca, GSK, HAL, Medscape, Menarini/Faes Farma, Mylan, Novartis, Nutricia, OM Pharma, Regeneron/Sanofi in the last 3 years. Dimitrios Mitsias is or recently was a speaker for AstraZeneca, Gerolymatos International, Novartis, Sanofi, in the last 3 years. George Konstantinou is or recently was a speaker and/or advisor for and/or has received research funding from AstraZeneca, Chiesi, GSK, Menarini, Novartis, Pfizer, Sanofi, and Vianex in the last 3 years. All other authors do not declare any conflicts of interest.
European Academy of Allergy and Clinical Immunology; Stallergenes
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources